Cramer: This could someday replace oxycodone

 In Health, Medical Marijuana

After GW Pharmaceuticals announced positive results of late-stage trials of a cannabis-based drug meant to treat children’s epilepsy, CNBC’s Jim Cramer said the medication could someday replace the opioid oxycodone as a leading prescription painkiller.

Prices for the British company’s U.S.-listed shares more than doubled on Monday on news of the test results for Epidiolex.

Cramer said on “Squawk on the Street” the drug could make doctors in the U.S. less hesitant to prescribe cannabis-based drugs. “If you want to prescribe actual medical marijuana, a real doctor is reluctant to do it because there is no uniform standard, and all you really want is the pure cannabinoid,” he said.



Recent Posts